CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED (02877)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chen Zhong | 01-Dec-14 | 01-Nov-22 | ED | Due to his intention to devote more time to pursue his personal interests | |
| Cheng Li | 03-Jul-06 | 01-Apr-23 | INED | To devote more time to pursue her personal interests | |
| Cheung Anthony Chun Yue | 01-Jan-19 | 01-Nov-21 | INED | ||
| Hou Jiangtao | 22-Jul-04 | 07-Jun-05 | ED | ||
| Huen Po Wah | 18-Jan-07 | CoSec | |||
| Hung Randy King Kuen | 17-Feb-14 | 30-Mar-17 | INED | ||
| 01-Jun-11 | 17-Feb-14 | NED | |||
| 07-Jun-05 | 30-Apr-10 | ED | |||
| Lee Brandelyn Ching Ton | 01-Oct-12 | 23-Jan-18 | ED | ||
| Lee Terence Bun Ching | 01-Jul-17 | CoSec | |||
| Li Huimin | 22-Jul-04 | ED | |||
| Li Lewis Kung Man | 10-Nov-04 | 30-May-08 | INED | ||
| Li Zhenjiang | 01-Dec-18 | Ch, Co-Fdr | |||
| 15-Oct-02 | 01-Dec-18 | Ch, CEO, Co-Fdr | |||
| Liu Shun Fai | 01-Nov-21 | INED | |||
| Liu Tiejun | 01-Nov-22 | 01-Nov-23 | ED | In order to devote more time to focus on his role as a vice president of Shineway Pharmaceutical Group Limited (an indirect wholly-owned subsidiary of the Company) | |
| Lou Sai Tong | 16-Aug-04 | 16-Nov-05 | CFO, CoSec | ||
| Luo Guoan | 16-Jun-17 | 01-Oct-22 | INED | In order to devote more time to pursue his personal interests | |
| Ma Terence Kwai Yuen | 06-May-08 | 17-Dec-09 | INED | ||
| Ren Dequan | 03-Jul-06 | 17-Feb-14 | INED | ||
| Sun Liutai | 09-Feb-10 | 01-Jan-19 | INED | ||
| Wang Guihua | 01-Apr-23 | INED | |||
| Wang Jianping | 10-Nov-04 | 03-Jul-06 | INED | ||
| Wang Zheng Pin | 01-Jun-13 | 01-Jan-16 | ED | ||
| Wang Zhihua | 22-Jul-04 | 01-Jun-13 | Co-Fdr, ED | ||
| Wong Mei Shan | 18-Jan-07 | 01-Jul-17 | CoSec | ||
| Xin Yunxia | 22-Jul-04 | Co-Fdr, ED | |||
| Xu Sheng | 01-Dec-18 | 02-Jul-19 | CEO | ||
| Yew Andric Yat On | 01-Oct-22 | INED | |||
| Zhou Chaofan | 10-Nov-04 | 03-Jul-06 | INED | ||
| Zhou Wencheng | 01-Oct-20 | NED |